Uncategorized

Sensorion to Host Key Opinion Leader Webinar on July 5, 2023; Confirms Upcoming Key Milestones

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces it will host a Key Opinion Leader webinar on Proof-of-Concept Phase 2a study preliminary results of SENS-401 for residual hearing preservation following cochlear implantation.

Sensorion to Host Key Opinion Leader Webinar on July 5, 2023; Confirms Upcoming Key Milestones Read More »

Scroll to Top